BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1113828)

  • 21. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
    Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
    Diabetes; 2006 Aug; 55(8):2277-85. PubMed ID: 16873691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of acyltransferases in fatty acid utilization.
    Borrebaek B; Christiansen R; Christophersen BO; Bremer J
    Circ Res; 1976 May; 38(5 Suppl 1):I16-21. PubMed ID: 1269090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lipidic myopathies].
    Muñoz-Blanco JL
    Rev Neurol; 1998 Apr; 26 Suppl 1():S72-80. PubMed ID: 9810593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The enzymes of mitochondrial fatty acid oxidation.
    Bennett MJ
    Clin Chim Acta; 1994 May; 226(2):211-24. PubMed ID: 7923814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The contribution of biochemistry to the diagnosis of muscular diseases].
    Finocchiaro G; Rimoldi M; Carrara F; Gellera C; Bloisi W; Di Donato S
    Riv Neurol; 1988; 58(1):37-44. PubMed ID: 3047847
    [No Abstract]   [Full Text] [Related]  

  • 26. Pathophysiology of fatty acid oxidation disorders.
    Bennett MJ
    J Inherit Metab Dis; 2010 Oct; 33(5):533-7. PubMed ID: 20824345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prenatal diagnosis of disorders of fatty acid transport and mitochondrial oxidation.
    Rinaldo P; Studinski AL; Matern D
    Prenat Diagn; 2001 Jan; 21(1):52-4. PubMed ID: 11180241
    [No Abstract]   [Full Text] [Related]  

  • 28. Exercise intolerance and the mitochondrial respiratory chain.
    DiMauro S
    Ital J Neurol Sci; 1999 Dec; 20(6):387-93. PubMed ID: 10937858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defects in long chain fatty acid oxidation presenting as severe cardiomyopathy and cardiogenic shock in infancy.
    Dereddy NR; Kronn D; Krishnan U
    Cardiol Young; 2009 Sep; 19(5):540-2. PubMed ID: 19691901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mitochondrial beta-oxidation defects].
    Woldseth B; Rootwelt T
    Tidsskr Nor Laegeforen; 2006 Mar; 126(6):756-9. PubMed ID: 16541168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined enzyme defect of mitochondrial fatty acid oxidation.
    Jackson S; Kler RS; Bartlett K; Briggs H; Bindoff LA; Pourfarzam M; Gardner-Medwin D; Turnbull DM
    J Clin Invest; 1992 Oct; 90(4):1219-25. PubMed ID: 1401059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Metabolism of fatty acids in the myocardium and muscles during physical exercise].
    Klepping J; Guilland JC; Moreau D
    Journ Annu Diabetol Hotel Dieu; 1980 May; ():131-49. PubMed ID: 7401420
    [No Abstract]   [Full Text] [Related]  

  • 33. Oxidation of short-chain fatty acids by the mitochondria of different types of muscles.
    Dvoráková L; Herbrychová A; Drahota Z
    Physiol Bohemoslov; 1970; 19(1):37-41. PubMed ID: 4249000
    [No Abstract]   [Full Text] [Related]  

  • 34. Fat metabolism during exercise: a review. Part I: fatty acid mobilization and muscle metabolism.
    Jeukendrup AE; Saris WH; Wagenmakers AJ
    Int J Sports Med; 1998 May; 19(4):231-44. PubMed ID: 9657362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Turning down lipid oxidation during heavy exercise--what is the mechanism?
    Sahlin K; Sallstedt EK; Bishop D; Tonkonogi M
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 7():19-30. PubMed ID: 19258655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defects in mitochondrial fatty acid oxidation: clinical presentations and their role in sudden infant death.
    Pollitt RJ
    Padiatr Padol; 1993; 28(1):13-7. PubMed ID: 8446423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation analysis in mitochondrial fatty acid oxidation defects: Exemplified by acyl-CoA dehydrogenase deficiencies, with special focus on genotype-phenotype relationship.
    Gregersen N; Andresen BS; Corydon MJ; Corydon TJ; Olsen RK; Bolund L; Bross P
    Hum Mutat; 2001 Sep; 18(3):169-89. PubMed ID: 11524729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake.
    Stanley CA; DeLeeuw S; Coates PM; Vianey-Liaud C; Divry P; Bonnefont JP; Saudubray JM; Haymond M; Trefz FK; Breningstall GN
    Ann Neurol; 1991 Nov; 30(5):709-16. PubMed ID: 1763895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Muscle symptoms and fat oxidation.
    Lancet; 1970 May; 1(7656):1096. PubMed ID: 4191970
    [No Abstract]   [Full Text] [Related]  

  • 40. The emerging role of the mitochondrial fatty-acid synthase (mtFASII) in the regulation of energy metabolism.
    Wehbe Z; Behringer S; Alatibi K; Watkins D; Rosenblatt D; Spiekerkoetter U; Tucci S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Nov; 1864(11):1629-1643. PubMed ID: 31376476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.